標(biāo)題: Titlebook: Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models; J. Miguel Oliveira,Rui L. Reis Book 2020 Springer Nature Switzerland AG [打印本頁(yè)] 作者: Espionage 時(shí)間: 2025-3-21 18:41
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models影響因子(影響力)
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models被引頻次
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models被引頻次學(xué)科排名
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models年度引用
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models年度引用學(xué)科排名
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models讀者反饋
書(shū)目名稱(chēng)Biomaterials- and Microfluidics-Based Tissue Engineered 3D Models讀者反饋學(xué)科排名
作者: 鄙視 時(shí)間: 2025-3-21 21:18
Microfluidics for Processing of Biomaterials,ic processing of biomaterials, mainly polymeric materials of natural origin, focusing on water-soluble polymers that form non-flowing phases after crosslinking. Some polysaccharides and proteins, including agarose, alginate, chitosan, gellan gum, hyaluronic acid, collagen, gelatin, and silk fibroin 作者: GRILL 時(shí)間: 2025-3-22 04:15 作者: paragon 時(shí)間: 2025-3-22 04:33 作者: cathartic 時(shí)間: 2025-3-22 09:19
Biomaterials and Microfluidics for Liver Models, engineered tissue construct were centered on the concept of seeding cells onto biomaterial scaffold. By means of innovative manufacturing machineries, the conception of a preformed scaffold became possible. Nowadays, several tissue engineering challenges are associated with applying this scaffold t作者: Merited 時(shí)間: 2025-3-22 14:17 作者: PACK 時(shí)間: 2025-3-22 17:35 作者: malign 時(shí)間: 2025-3-22 22:44
Biomaterials and Microfluidics for Drug Discovery and Development,or pathogenesis. Together with the potential of biomaterials, its combination with microfluidics represents the ability to more closely mimic cells’ natural microenvironment concerning its three-dimensional (3D) nature and continuous perfusion with nutrients and cells’ crosstalk. Due to miniaturizat作者: Modify 時(shí)間: 2025-3-23 02:53
Dynamic Culture Systems and 3D Interfaces Models for Cancer Drugs Testing,oduction of antibiotics. The use of dynamic systems, such as bioreactors, had been already applied in the food industry in fermentation processes and started being used for the development of pharmaceutical agents from this point on. In the last decades, the use of bioreactors and microfluidic syste作者: 擴(kuò)張 時(shí)間: 2025-3-23 07:28
Nanoparticles and Microfluidic Devices in Cancer Research,anotechnology has been presenting promising theranostic approaches to tackle cancer, as the development of nanoparticle-based therapies. But, regardless of the promising outcomes within . settings, its translation into the clinics has been delayed. One of the main reasons is the lack of an appropria作者: 悶熱 時(shí)間: 2025-3-23 12:43 作者: Melatonin 時(shí)間: 2025-3-23 14:54
Rekonstruktive Bildungsforschungion and increased experimental throughput, microfluidics have generated significant interest in the drug discovery and development domain. Herein, the most recent advances in the field of microfluidics for drug discovery are overviewed, and the role of biomaterials in 3D . models and the contribution of organ-on-a-chip technologies highlighted.作者: Anecdote 時(shí)間: 2025-3-23 19:46
0065-2598 hows how biomaterials and microfluidic devices are key techn.This contributed volume reviews the latest advances on relevant 3D tissue engineered .in vitro .models of disease making use of biomaterials and microfluidics. The main focus of this book is on advanced biomaterials and microfluidics techn作者: 因無(wú)茶而冷淡 時(shí)間: 2025-3-24 02:13 作者: organic-matrix 時(shí)間: 2025-3-24 03:09
Exkurs: Ergebnisse eines Workshops,edicated software for microfluidic studies can enable performing high throughput and good quality automated experiments investigating regeneration and degeneration processes in models well emulating central nervous system structures.作者: BUDGE 時(shí)間: 2025-3-24 09:50 作者: Lumbar-Stenosis 時(shí)間: 2025-3-24 11:34
https://doi.org/10.1007/978-3-8349-9829-3those that directly impact its processability using microfluidics. Furthermore, some microfluidic-based processing techniques are presented, describing their suitability to process materials with different sol-gel transition mechanisms.作者: 瘋狂 時(shí)間: 2025-3-24 14:55 作者: 胖人手藝好 時(shí)間: 2025-3-24 20:41 作者: byline 時(shí)間: 2025-3-25 00:41 作者: 熱烈的歡迎 時(shí)間: 2025-3-25 06:10 作者: MAIM 時(shí)間: 2025-3-25 10:05
https://doi.org/10.1007/978-3-8349-9829-3 . models do not truly replicate the native bone tissue environment. For so, new and improved . tissue models are necessary to obtain more reliable data, not only in a development point of view, but also to fasten the translation of new drugs into the clinics. In this reasoning, tissue-engineering s作者: 不妥協(xié) 時(shí)間: 2025-3-25 15:31
https://doi.org/10.1007/978-3-8349-9829-3ic processing of biomaterials, mainly polymeric materials of natural origin, focusing on water-soluble polymers that form non-flowing phases after crosslinking. Some polysaccharides and proteins, including agarose, alginate, chitosan, gellan gum, hyaluronic acid, collagen, gelatin, and silk fibroin 作者: 愉快么 時(shí)間: 2025-3-25 17:24 作者: 案發(fā)地點(diǎn) 時(shí)間: 2025-3-25 23:32
https://doi.org/10.1007/978-3-8349-9829-3 rates of new drugs in clinical trials, which threaten cancer patient prognosis. Tremendous efforts have been directed towards the development of a new generation of highly predictable pre-clinical models capable to reproduce . the biological complexity of the human body. Recent advances in nanotech作者: 離開(kāi)就切除 時(shí)間: 2025-3-26 01:16
Konzeptionen gegen Jugendarbeitslosigkeit engineered tissue construct were centered on the concept of seeding cells onto biomaterial scaffold. By means of innovative manufacturing machineries, the conception of a preformed scaffold became possible. Nowadays, several tissue engineering challenges are associated with applying this scaffold t作者: 疲勞 時(shí)間: 2025-3-26 05:27
Exkurs: Ergebnisse eines Workshops,Wide range of micro-chambers with diversity of channel systems and multiple compartments enable users to create models which closely mimic nervous tissue structure which nowadays is often called as brain-on-a-chip technology. Heretofore experiments showing the influence of substance gradients, cell 作者: 不出名 時(shí)間: 2025-3-26 11:30 作者: 中子 時(shí)間: 2025-3-26 16:06 作者: Stagger 時(shí)間: 2025-3-26 17:12 作者: miscreant 時(shí)間: 2025-3-26 22:50 作者: 植物學(xué) 時(shí)間: 2025-3-27 01:20
https://doi.org/10.1007/978-3-030-36588-2Biomaterials; Microfluids; In Vitro Models; Tissue Engineering; Organ-/Body-on-a Chip作者: 半圓鑿 時(shí)間: 2025-3-27 09:10
978-3-030-36590-5Springer Nature Switzerland AG 2020作者: committed 時(shí)間: 2025-3-27 12:12
https://doi.org/10.1007/978-3-8349-9829-3gineered tissues in a single step. The ability to print spatially controlled structures composed of different biomaterials, growth factors and cells caught the attention of scientists for the development of more efficient . models. Additionally, it allows obtaining microfluidic devices and/or engine作者: packet 時(shí)間: 2025-3-27 16:16 作者: Host142 時(shí)間: 2025-3-27 17:59 作者: cortisol 時(shí)間: 2025-3-27 22:22 作者: glucagon 時(shí)間: 2025-3-28 02:38 作者: 頌揚(yáng)國(guó)家 時(shí)間: 2025-3-28 08:42
https://doi.org/10.1007/978-3-658-25782-8more prevalent in certain types of cancer, such as glioblastoma multiform and in high-grade metastatic cancers like bone metastasis of breast or prostatic cancer. The difficulty in obtaining novel drugs for these purposes is mostly linked to the barriers around the tumors, which these bioactive mole作者: 注意到 時(shí)間: 2025-3-28 12:00 作者: flimsy 時(shí)間: 2025-3-28 16:34 作者: 脫水 時(shí)間: 2025-3-28 20:08
Microfluidic Devices and Three Dimensional-Printing Strategies for , Models of Bone,gineered tissues in a single step. The ability to print spatially controlled structures composed of different biomaterials, growth factors and cells caught the attention of scientists for the development of more efficient . models. Additionally, it allows obtaining microfluidic devices and/or engine作者: 眨眼 時(shí)間: 2025-3-29 02:11
Organs-on-a-Chip,past decade, and some of the opportunities offered by MPS technology that are not available through current standard two-dimensional cell cultures, or three-dimensional organoid systems. This chapter will outline future avenues of research in the MPS field, how cutting-edge biotechnology advances ar作者: 不給啤 時(shí)間: 2025-3-29 05:50
Engineering Patient-on-a-Chip Models for Personalized Cancer Medicine,metic and personalized . platforms. The individualized models provide a more accurate and physiological environment to predict tumor progression on patients and their response to drugs. In this chapter, we describe the latest advances in the field of cancer patient-on-a-chip, and discuss about their
